Follow
Ganji Purnachandra Nagaraju PhD, DSc, FAACC
Ganji Purnachandra Nagaraju PhD, DSc, FAACC
Assistant Professor, School of Medicine, University of Alabama
Verified email at emory.edu
Title
Cited by
Cited by
Year
Broad targeting of angiogenesis for cancer prevention and therapy
Z Wang, C Dabrosin, X Yin, MM Fuster, A Arreola, WK Rathmell, ...
Seminars in cancer biology 35, S224-S243, 2015
5142015
Reproductive regulators in decapod crustaceans: an overview
GPC Nagaraju
Journal of Experimental Biology 214 (1), 3-16, 2011
3422011
Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer
KGK Deepak, R Vempati, GP Nagaraju, VR Dasari, S Nagini, DN Rao, ...
Pharmacological research 153, 104683, 2020
3202020
Designing a broad-spectrum integrative approach for cancer prevention and treatment
KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ...
Seminars in cancer biology 35, S276-S304, 2015
3052015
Is methyl farnesoate a crustacean hormone?
GPC Nagaraju
Aquaculture 272 (1-4), 39-54, 2007
2192007
Matrix metalloproteinases: their functional role in lung cancer
N Merchant, GP Nagaraju, B Rajitha, S Lammata, KK Jella, ZS Buchwald, ...
Carcinogenesis 38 (8), 766-780, 2017
1882017
ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis
SJ Chung, GP Nagaraju, A Nagalingam, N Muniraj, P Kuppusamy, ...
Autophagy 13 (8), 1386-1403, 2017
1702017
Molecular mechanisms underlying the divergent roles of SPARC in human carcinogenesis
GP Nagaraju, R Dontula, BF El-Rayes, SS Lakka
Carcinogenesis 35 (5), 967-973, 2014
1562014
Hypoxia inducible factor-1α: Its role in colorectal carcinogenesis and metastasis
GP Nagaraju, PV Bramhachari, G Raghu, BF El-Rayes
Cancer letters 366 (1), 11-18, 2015
1302015
FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple negative breast cancer cells
LT Taliaferro-Smith, E Oberlick, T Liu, T McGlothen, T Alcaide, R Tobin, ...
Oncotarget 6 (7), 4757, 2015
1272015
Understanding novel COVID-19: its impact on organ failure and risk assessment for diabetic and cancer patients
B Dariya, GP Nagaraju
Cytokine & growth factor reviews 53, 43-52, 2020
1172020
Antiangiogenic effects of ganetespib in colorectal cancer mediated through inhibition of HIF-1α and STAT-3
PN Ganji, W Park, J Wen, H Mahaseth, J Landry, AB Farris, F Willingham, ...
Angiogenesis 16, 903-917, 2013
1162013
Lifelong running reduces oxidative stress and degenerative changes in the testes of mice
S Chigurupati, TG Son, DH Hyun, JD Lathia, MR Mughal, J Savell, SC Li, ...
Journal of Endocrinology 199 (2), 333-341, 2008
1102008
The impact of curcumin on breast cancer
GP Nagaraju, S Aliya, SF Zafar, R Basha, R Diaz, BF El-Rayes
Integrative Biology 4 (9), 996-1007, 2012
1072012
Role of hypoxia-inducible factors (HIF) in the maintenance of stemness and malignancy of colorectal cancer
R Vadde, S Vemula, R Jinka, N Merchant, PV Bramhachari, GP Nagaraju
Critical reviews in oncology/hematology 113, 22-27, 2017
1042017
Pleiotropic effects of genistein in metabolic, inflammatory, and malignant diseases
GP Nagaraju, SF Zafar, BF El-Rayes
Nutrition reviews 71 (8), 562-572, 2013
1022013
Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer
GP Nagaraju, TE Long, W Park, JC Landry, LT Taliaferro‐Smith, AB Farris, ...
Molecular carcinogenesis 54 (10), 1147-1158, 2015
1012015
Anti-cancer role of SPARC, an inhibitor of adipogenesis
GPC Nagaraju, D Sharma
Cancer treatment reviews 37 (7), 559-566, 2011
1002011
Epigenetics in hepatocellular carcinoma
GP Nagaraju, B Dariya, P Kasa, S Peela, BF El-Rayes
Seminars in cancer biology 86, 622-632, 2022
982022
Engineered nanoparticles for imaging and drug delivery in colorectal cancer
E Pavitra, B Dariya, G Srivani, SM Kang, A Alam, PR Sudhir, MA Kamal, ...
Seminars in cancer Biology 69, 293-306, 2021
972021
The system can't perform the operation now. Try again later.
Articles 1–20